Management Decisions for Metastatic Castration-resistant Prostate Cancer in 2024
Authors:
- 19 October 2024
- journal article
- editorial
- Published by Elsevier in European Urology
- Vol. 87 (1) , 47-48
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic ReviewEuropean Urology, 2024
- [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trialThe Lancet Oncology, 2024
- Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO)Journal of Clinical Oncology, 2023
- Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trialThe Lancet Oncology, 2023
- PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trialThe Lancet Oncology, 2022
- Activation of the AKT pathway and outcomes in patients (pts) treated with or without ipatasertib (ipat) in metastatic castration-resistant prostate cancer (mCRPC): Next-generation sequencing (NGS) data from the phase III IPATential150 trial.Journal of Clinical Oncology, 2022
- Olaparib for Metastatic Castration-Resistant Prostate CancerNew England Journal of Medicine, 2020
- Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate CancerNew England Journal of Medicine, 2019
- Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint BlockadeJAMA Oncology, 2019
- Clinical determinants for successful circulating tumor DNA analysis in prostate cancerThe Prostate, 2019